Senior writer at GMS, GlobalData.
Previously feature writer at Just Style.
TABBIE Honourable Mention winner.
BA (Open) in English | BSc (Hons) in Geosciences. Also a graphic designer with certificates in Digital Marketing and Social Media. Lives by the beach.
According to packaging expert Alexander Schäfer, developing the ideal packaging strategy for your global drug launch involves analyzing market trends, understanding consumer expectations, and considering the benefits of partnering with a contract packaging organization (CPO).
Good communication is vital for running a successful clinical trial, and ensuring the secondary packaging is both efficient and traceable is essential. Clinical Trials Arena sat down with experts from BAP Pharma to discuss how transparency is key when considering your clinical trial supply strategy.
Participant drop-out in clinical trials affects data quality, can reduce a study’s power and can also introduce unwanted bias to your remaining results. How can you reduce drop-out, save time and resources, and maintain participant engagement throughout the entirety of your trial?
Cross-border cooperation is growing stronger in Europe, with key clusters such as Benelux and the Nordics accelerating joint procurement agreements in order to improve medicine access and increase negotiating power.
Climate change has the potential to cause major disruptions to the global pharma supply chain and tragic health impacts for the global population. Many in the pharma industry are making efforts to reduce emissions and implement more eco-friendly processes to ensure patients can continue to access their medicines efficiently and sustainably.
Brazil has the largest pharmaceutical market in Latin America, and recent political changes have raised speculation about what other changes could be in store. We take a look at the country’s pharma market and explore what could be around the corner in terms of legislation.